SOPHiA GENETICS S.A. (SOPH) Financials

SOPH Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 198.4 million 115.2 million
March 31, 2026 157.0 million 111.3 million
Dec. 31, 2025 163.0 million 115.9 million
Sept. 30, 2025 163.5 million 102.8 million

SOPH Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -10.4 million 4.5 million
March 31, 2026 -17.1 million 3.3 million
Dec. 31, 2025 -9.3 million 3.9 million
Sept. 30, 2025 -8.9 million 4.1 million

SOPH Net Income

No data available :(

SOPH Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 107.7 million 48.0 million 13.8 million
March 31, 2026 65.4 million 47.8 million 14.6 million
Dec. 31, 2025 70.3 million 47.7 million 15.3 million
Sept. 30, 2025 81.6 million 47.6 million 15.8 million

SOPH Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 83.9 million
March 31, 2026 71.1 million
Dec. 31, 2025 68.2 million
Sept. 30, 2025 67.8 million

SOPH Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 2.7 million 8.7 million 26.4 million 11.2 million
March 31, 2026 878000 11.1 million 22.6 million 8.8 million
Dec. 31, 2025 348419 8.5 million 24.2 million -
Sept. 30, 2025 106000 9.4 million 22.6 million 8.7 million

SOPH Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 23.3 million 8.2 million
March 31, 2026 21.7 million 6.9 million
Dec. 31, 2025 21.7 million 7.0 million
Sept. 30, 2025 19.5 million 6.6 million

SOPH

Price: $7.87

52 week price:
3.10
8.98

Earnings Per Share: -1.16 USD

Exchange: NMS

Sector: Healthcare

Industry: Health Information Services

Country: Switzerland

Volume: 4190

Market Capitalization: 696.3 million

Links: